Literature DB >> 1992482

Thyrotropin-luteinizing hormone/chorionic gonadotropin receptor extracellular domain chimeras as probes for thyrotropin receptor function.

Y Nagayama1, H L Wadsworth, G D Chazenbalk, D Russo, P Seto, B Rapoport.   

Abstract

To define the sites in the extracellular domain of the human thyrotropin (TSH) receptor that are involved in TSH binding and signal transduction we constructed chimeric thyrotropin-luteinizing hormone/chorionic gonadotropin (TSH-LH/CG) receptors. The extracellular domain of the human TSH receptor was divided into five regions that were replaced, either singly or in various combinations, with homologous regions of the rat LH/CG receptor. The chimeric receptors were stably expressed in Chinese hamster ovary cells. The data obtained suggest that the carboxyl region of the extracellular domain (amino acid residues 261-418) and particularly the middle region (residues 171-260) play a role in signal transduction. The possibility is also raised of an interaction between the amino and carboxyl regions of the extracellular domain in the process of signal transduction. With respect to hormone binding, substitution of the entire extracellular domain of the LH/CG receptor for the corresponding region of the TSH receptor resulted in high-affinity human CG binding with complete loss of TSH binding. Surprisingly, however, there was at least one chimera with a substitution at each of the five domains that still retained high-affinity TSH binding. Substitution of residues 1-170 of the TSH receptor with the corresponding region of the LH/CG receptor was associated with the retention of high-affinity TSH binding but ligand specificity was lost in that TSH and human CG could interact functionally with the receptor. In summary, these studies suggest that the middle region and carboxyl half of the extracellular domain of the TSH receptor are involved in signal transduction and that the TSH-binding region is likely to span the entire extracellular domain, with multiple discontinuous contact sites.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1992482      PMCID: PMC50922          DOI: 10.1073/pnas.88.3.902

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

Review 1.  Epitopes on protein antigens: misconceptions and realities.

Authors:  W G Laver; G M Air; R G Webster; S J Smith-Gill
Journal:  Cell       Date:  1990-05-18       Impact factor: 41.582

2.  An insertion in the human thyrotropin receptor critical for high affinity hormone binding.

Authors:  H L Wadsworth; G D Chazenbalk; Y Nagayama; D Russo; B Rapoport
Journal:  Science       Date:  1990-09-21       Impact factor: 47.728

3.  Preparation of biologically active 125I-TSH.

Authors:  I D Goldfine; S M Amir; A W Petersen; S H Ingbar
Journal:  Endocrinology       Date:  1974-11       Impact factor: 4.736

4.  Na+ modulates the affinity of the lutropin/choriogonadotropin receptor.

Authors:  K Buettner; M Ascoli
Journal:  J Biol Chem       Date:  1984-12-25       Impact factor: 5.157

5.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

6.  CD14 is a member of the family of leucine-rich proteins and is encoded by a gene syntenic with multiple receptor genes.

Authors:  E Ferrero; C L Hsieh; U Francke; S M Goyert
Journal:  J Immunol       Date:  1990-07-01       Impact factor: 5.422

7.  The testicular receptor for follicle stimulating hormone: structure and functional expression of cloned cDNA.

Authors:  R Sprengel; T Braun; K Nikolics; D L Segaloff; P H Seeburg
Journal:  Mol Endocrinol       Date:  1990-04

8.  The functional expression of recombinant human thyrotropin receptors in nonthyroidal eukaryotic cells provides evidence that homologous desensitization to thyrotropin stimulation requires a cell-specific factor.

Authors:  G D Chazenbalk; Y Nagayama; K D Kaufman; B Rapoport
Journal:  Endocrinology       Date:  1990-09       Impact factor: 4.736

9.  Periodicity of leucine and tandem repetition of a 24-amino acid segment in the primary structure of leucine-rich alpha 2-glycoprotein of human serum.

Authors:  N Takahashi; Y Takahashi; F W Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  33 in total

Review 1.  The ovarian gonadotropin receptors in health and disease.

Authors:  Paul A Fowler; Ilpo T Huhtaniemi
Journal:  Rev Endocr Metab Disord       Date:  2002-01       Impact factor: 6.514

2.  Insight into thyroid-stimulating autoantibody interaction with the thyrotropin receptor N-terminus based on mutagenesis and re-evaluation of ambiguity in this region of the receptor crystal structure.

Authors:  Sepehr Hamidi; Chun-Rong Chen; Sandra M McLachlan; Basil Rapoport
Journal:  Thyroid       Date:  2011-08-11       Impact factor: 6.568

Review 3.  Models of glycoprotein hormone receptor interaction.

Authors:  William R Moyle; Win Lin; Rebecca V Myers; Donghui Cao; John E Kerrigan; Michael P Bernard
Journal:  Endocrine       Date:  2005-04       Impact factor: 3.633

4.  Two-subunit structure of the human thyrotropin receptor.

Authors:  H Loosfelt; C Pichon; A Jolivet; M Misrahi; B Caillou; M Jamous; B Vannier; E Milgrom
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

Review 5.  Differential action of glycoprotein hormones: significance in cancer progression.

Authors:  Vijayakumar Govindaraj; Swathy V Arya; A J Rao
Journal:  Horm Cancer       Date:  2013-10-16       Impact factor: 3.869

Review 6.  Molecular insights into TSH receptor abnormality and thyroid disease.

Authors:  D Russo; F Arturi; E Chiefari; S Filetti
Journal:  J Endocrinol Invest       Date:  1997-01       Impact factor: 4.256

7.  Follitropin receptors contain cryptic ligand binding sites.

Authors:  Win Lin; Michael P Bernard; Donghui Cao; Rebecca V Myers; John E Kerrigan; William R Moyle
Journal:  Mol Cell Endocrinol       Date:  2006-10-23       Impact factor: 4.102

8.  Identification of key amino acid residues in a thyrotropin receptor monoclonal antibody epitope provides insight into its inverse agonist and antagonist properties.

Authors:  Chun-Rong Chen; Sandra M McLachlan; Basil Rapoport
Journal:  Endocrinology       Date:  2008-04-03       Impact factor: 4.736

9.  Lutropins appear to contact two independent sites in the extracellular domain of their receptors.

Authors:  M P Bernard; R V Myers; W R Moyle
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

10.  The thyrotropin receptor hinge region as a surrogate ligand: identification of loci contributing to the coupling of thyrotropin binding and receptor activation.

Authors:  Chun-Rong Chen; Larry M Salazar; Sandra M McLachlan; Basil Rapoport
Journal:  Endocrinology       Date:  2012-10       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.